The U.S. Senate’s permanent subcommittee on investigations will probe Mylan Pharmaceuticals’ pricing of the allergy auto-injector EpiPen, according to a press release issued on Wednesday. The release described the probe as a “preliminary inquiry.” Mylan has been criticized